Please login to the form below

Not currently logged in
Email:
Password:

NovoMix 30

This page shows the latest NovoMix 30 news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk recalls insulin

Novo Nordisk recalls insulin

Novo Nordisk recalls insulin. Batches of prefilled NovoMix 30 pens found to have incorrect amount of diabetes treatment. ... Diabetes patients in Europe were warned to be on alert after Novo Nordisk announced a recall of several batches of its NovoMix

Latest news

  • The impact of insulin

    The company has modified the product into the more user-friendly formulations: NovoMix 30 is a dual-release insulin analog formulation of one rapid- and one intermediate-acting form of insulin ... aspart delivered in a single injection, and NovoMix 50

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics